Genetic Technologies Ltd. (GENE) announced Tuesday morning that it has signed an exclusive worldwide license agreement with The University of Melbourne to develop and commercialize a colorectal cancer risk assessment test.
from RTT - Before the Bell http://ift.tt/2gjUjgf
via IFTTT
No comments:
Post a Comment